Original-Research

029 Group SE (von NuWays AG): HOLD 02.10.2025, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
029 Group 41,30 EUR +0,49 % Lang & Schwarz

^

Original-Research: 029 Group SE - from NuWays AG

02.10.2025 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to 029 Group SE

Company Name: 029 Group SE

ISIN: DE000A2LQ2D0

Reason for the research: Update

Recommendation: HOLD

from: 02.10.2025

Target price: EUR 22.00

Target price on sight of: 12 months

Last rating change:

Analyst: Christian Sandherr

H1 report reveals strong dev. of key holdings; up to HOLD

H1 2025 net loss came in at EUR 237k (vs. EUR 697k net income in H1 2024) due to

the absence of divestments. Mind you, in H1 2024 029 sold its stake in

Emerald Stay, which resulted on a EUR 0.94m book gain. Besides that, operating

expenses remained largely unchanged compared to previous year's figures.

Cash at the end of the first half stood at EUR 65k while liabilities slightly

increased to EUR 700k (+ EUR 100k).

More importantly, key holdings continue to develop in line with

expectations. Limestone Capital (eNuW: 86% of implied fair NAV) successfully

opened its 5-star hotel on Mallorca and the former Nobu location in London

just yesterday, increasing its locations to 10. Next to the hotel brand

Aethos, Limestone also acquired a majority stake in LOISIUM Wine & Spa

Hotels and initiated an investment program of over EUR 100m to develop four

additional properties in Italy and France. Limestone also announced the

launch of its third hotel brand, Crafted, which is seen to open its first

property in East Sussex still this year. With AUMs of over EUR 1bn, Limestone

is quickly developing into a leading European player within its niche.

TRIP Drinks (eNuW: 9% of implied fair NAV), recorded >100% sales growth as

the company is increasingly gaining traction across the UK but also new end

markets such as France and the US. Based on the reported NAV and 029's 5%

stake, the valuation of TRIP should have increase by 51% yoy to EUR 203m. As

seen with the acquisition of its US peer Poppi and other transactions in

that space, strategic buyers (PepsiCo in the case of Poppi) are willing to

pay 4-5x sales.

hotelbird, a leading solution provider for a seamless digital guest journey

within the hotel industry, continuous to grow organically while being able

to finance itself. For instance, the company is currently rolling out its

solutions across hotels of the Motel One group. Since the listing of its

peer ReGuest, the implied valuation (25-30x EV/Sales FY25e) provides

confidence in a significant valuation uplift compared to the holdings

current NAV in case of an exit or potential funding round.

Brother's Bond entered into a phase of international expansion during H1 (so

far US pure play), supported by fresh growth capital. This strategy is

already bearing fruit as the company already entered into several new

partnerships. For instance, the company's bourbon is now available across

the Gebr. Heinemann (leading duty free shop at airports and on cruise ships)

locations. Thanks to the recent strong growth, Brother's Bond also reached

profitability.

Fjör, 029's skincare investment within the premium segment is broadening its

product portfolio with the launch of a new moisturizer in June, world's

first hydrolytic body care product. At a NAV of EUR 0.5m, Fjör's impact on the

group's valuation remains limited.

We upgrade to HOLD (old: SELL) due to higher fair NAVs for Limestone Capital

(strong AUM growth) and TRIP Drinks (implied NAV following recent funding

round) with a EUR 22 PT (old: EUR 15.80).

You can download the research here:

https://eqs-cockpit.com/c/fncls.ssp?u=6274e6bc3ac5b3e4213c9d0904f410f4

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---------------------------------------------------------------------------

2207204 02.10.2025 CET/CEST

°

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer